One investor apparently believes that the upside is limited in United Therapeutics after a selloff last month. optionMONSTER’s trade monitors detected the sale of 1,000 December 47.50 calls
Read More:
Ceiling seen on United Therapeutics
One investor apparently believes that the upside is limited in United Therapeutics after a selloff last month. optionMONSTER’s trade monitors detected the sale of 1,000 December 47.50 calls
Read More:
Ceiling seen on United Therapeutics